NKF K/DOQI GUIDELINES 2000

General Acknowledgements

The NKF gratefully acknowledges the support of Amgen, Inc., Founding and Principal Sponsor of K/DOQI, and of Luitpold Pharmaceuticals, in the K/DOQI update process. We also thank Watson Pharmaceuticals, Inc., Nephrology Division (formerly Schein Pharmaceuticals, Inc.) for their support of K/DOQI implementation.